FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia ...Middle East

PR Newswire - News
FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia
SILVER SPRING, Md., Sept. 26, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. It is the first antipsychotic drug approved to treat schizophrenia that...

Hence then, the article about fda approves drug with new mechanism of action for treatment of schizophrenia was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia )

Apple Storegoogle play

Last updated :

Also on site :